Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ilam University of Medical Sciences

Worldwide prevalence of microbial agents' coinfection among COVID-19 patients: A comprehensive updated systematic review and meta-analysis

Tue Dec 6 01:58:09 2022

(UNSPECIFIED) Worldwide prevalence of microbial agents' coinfection among COVID-19 patients: A comprehensive updated systematic review and meta-analysis. Journal of Clinical Laboratory Analysis. p. 13. ISSN 0887-8013

Full text not available from this repository.

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Background To provide information about pathogens' coinfection prevalence with SARS-CoV-2 could be a real help to save patients' lives. This study aims to evaluate the pathogens' coinfection prevalence among COVID-19 patients. Method In order to find all of the relevant articles, we used systematic search approach. Research-based databases including PubMed, Web of Science, Embase, and Scopus, without language restrictions, were searched to identify the relevant bacterial, fungal, and viral coinfections among COVID-19 cases from December 1, 2019, to August 23, 2021. In order to dig deeper, other scientific repositories such as Medrxiv were probed. Results A total of 13,023 studies were found through systematic search. After thorough analysis, only 64 studies with 61,547 patients were included in the study. The most common causative agents of coinfection among COVID-19 patients were bacteria (pooled prevalence: 20.97; 95 CI: 15.95-26.46; I-2: 99.9) and less frequent were virus coinfections (pooled prevalence: 12.58; 95 CI: 7.31-18.96; I-2: 98.7). The pooled prevalence of fungal coinfections was also 12.60 (95 CI: 7.84-17.36; I-2: 98.3). Meta-regression analysis showed that the age sample size and WHO geographic region did not influenced heterogeneity. Conclusion We identified a high prevalence of pathogenic microorganism coinfection among COVID-19 patients. Because of this rate of coinfection empirical use of antibacterial, antifungal, and antiviral treatment are advisable specifically at the early stage of COVID-19 infection. We also suggest running simultaneously diagnostic tests to identify other microbiological agents' coinfection with SARS-CoV-2.

Item Type: Article
Creators:
CreatorsEmail
Pakzad, R.UNSPECIFIED
Malekifar, P.UNSPECIFIED
Shateri, Z.UNSPECIFIED
Zandi, M.UNSPECIFIED
Rezayat, S. A.UNSPECIFIED
Soleymani, M.UNSPECIFIED
Karimi, M. R.UNSPECIFIED
Ahmadi, S. E.UNSPECIFIED
Shahbahrami, R.UNSPECIFIED
Pakzad, I.UNSPECIFIED
Abdi, F.UNSPECIFIED
Farahani, A.UNSPECIFIED
Soltani, S.UNSPECIFIED
Kesheh, M. M.UNSPECIFIED
Hosseini, P.UNSPECIFIED
Keywords: coinfection coronavirus COVID-19 meta-analysis systematic review clinical characteristics bacterial coinfection secondary infections influenza-virus sars-cov-2 wuhan features outcomes Medical Laboratory Technology
Divisions:
Page Range: p. 13
Journal or Publication Title: Journal of Clinical Laboratory Analysis
Journal Index: ISI
Identification Number: https://doi.org/10.1002/jcla.24151
ISSN: 0887-8013
Depositing User: مهندس مهدی شریفی
URI: http://eprints.medilam.ac.ir/id/eprint/3722

Actions (login required)

View Item View Item